The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Sepsis Market At The End Of The 2026–2030 Forecast Period?
The sepsis market’s scale has substantially increased in recent years. It is projected to expand from $1.02 billion in 2025 to $1.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. The growth observed in the historical period was driven by factors such as high sepsis incidence, improved hospital care standards, the adoption of clinical protocols, the development of sepsis awareness programs, and advanced ICU setups.
The sepsis market size is expected to undergo significant expansion in the coming years, with projections indicating a rise to $1.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This forecasted growth can be attributed to advancements like AI-assisted early detection, the broader implementation of point-of-care monitoring, integration with EHR systems, the development of advanced therapeutics for sepsis, and the worldwide embrace of sepsis management guidelines. Noteworthy trends anticipated during this period include new early sepsis detection tools, AI-powered risk scoring, point-of-care sepsis monitors, tele-ICU integration, and solutions for protocol-driven treatment.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21286&type=smp
What Drivers Are Shaping The Future Growth Of The Sepsis Market?
The future expansion of the sepsis market is anticipated to be fueled by the rising prevalence of infectious diseases. Infectious illnesses are defined as conditions resulting from the invasion of the body by pathogens such as bacteria, viruses, fungi, or parasites. Examples of prevalent infectious diseases encompass tuberculosis, influenza, ringworm, and malaria, which are transmitted via direct contact, tainted sources, or vectors like insects. Factors contributing to the occurrence of infectious diseases include population growth, global interconnectedness, alterations in the environment, the emergence of drug-resistant pathogens, and deficiencies within healthcare infrastructure. Sepsis represents a critical complication stemming from infectious diseases, occurring when the body reacts excessively to an infection, resulting in systemic inflammation and possible organ dysfunction. As an illustration, data from November 2024, provided by the Centers for Disease Control and Prevention, a US-based government agency for public health, revealed that in 2023, the United States recorded 9,633 cases of tuberculosis (TB), indicating a 15.6% rise from 8,332 cases reported in 2022. Consequently, the escalating burden posed by infectious diseases is propelling the expansion of the sepsis market.
What Segment Types Make Up The Sepsis Market?
The sepsis market covered in this report is segmented –
1) By Type: Diagnosis, Therapeutics
2) By Pathogen: Bacterial, Viral, Fungal
3) By Application: Severe Sepsis, Septic Shock
4) By End User: Hospitals, Pathology, Reference Laboratories
Subsegments:
1) By Diagnosis: Blood Tests, Imaging Techniques, Microbiological Culture Tests, Biomarker Tests, Other Diagnostic Methods
2) By Therapeutics: Antibiotics, Antifungal Agents, Vasopressors, Immunoglobulins, Corticosteroids, Other Therapeutic Options
Which Upcoming Trends Are Expected To Influence The Sepsis Market?
Major companies operating in the sepsis market are concentrating on developing technologically advanced platforms, such as those powered by artificial intelligence (AI), to improve early diagnosis, enhance treatment precision, and predict patient outcomes. This effort ultimately aims to reduce mortality rates and elevate healthcare efficiency in sepsis management. For instance, in June 2024, Predicate Healthcare Performance Group (HPG), a US-based healthcare company, launched its AI software platform, OpenDX. This innovative platform combines AI-powered diagnostics with wearable biosensors, allowing healthcare providers to detect early signs of sepsis. This technology assists in sepsis diagnosis and holds the potential to expand to other health conditions, highlighting the critical role of technology in diagnostics. Predicate’s chest sensor specifically aids healthcare workers in identifying early sepsis signs, which is a challenging and frequently missed diagnosis.
Who Are The Key Players Driving Competition In The Sepsis Market?
Major companies operating in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Asahi Kasei Corporation, Becton Dickinson and Company, bioMérieux SA, QuidelOrtho Corporation, DiaSorin S.p.A., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.
Read the full sepsis market report here:
https://www.thebusinessresearchcompany.com/report/sepsis-global-market-report
Which Geographic Regions Are Influencing Demand In The Sepsis Market?
North America was the largest region in the sepsis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Sepsis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=21286&type=smp
Browse Through More Reports Similar to the Global Sepsis Market 2026, By The Business Research Company
Infectious Disease Diagnostics Testing Global Market Report
Hemostasis Diagnostic Devices And Equipment Global Market Report
Gastrointestinal Pathogen Testing Global Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model